Preliminary Programme

THURSDAY

Thursday, September 20

08:00-9:00 Registration
09.00-10.00 Welcome / Intro
09.00-09:10 Welcome to Madrid /Opening Remarks
Laura Peña, PhD
09.10-09:30 Welcome from Local Authorities
09.30-10:00 Goals/Objectives of the Symposium
Massimo Cristofanilli, MD/ Valerie Fraser
10.00-11.00 Opening Session- Advancements in the Management of Breast Cancer
Moderator: Massimo Cristofanilli, MD
10.00-10:20 Neoadjuvant-Adjuvant Treatments in BC
Beth Overmoyer, MD
10:20-10:40 Advancements in HR+ MBC
Massimo Cristofanilli, MD
10:40-11:00 Precision Medicine and Liquid Biopsies
MJ Serrano Fernandez, MD
11:00-11:30 Coffee  BREAK and poster viewing
11:30-13:00 Session 1: DIAGNOSTICS and IMAGING
Moderator: Wendy Woodward, MD, PhD
11:30-11:50 Challenges in Diagnosis of IBC vs. LABC
Beth Overmoyer, MD
o IBC vs. Advanced BC
o Limited vs. Extensive Stage
11:50-12:20 Development of novel targeted therapy in IBC based on cancer microenviroment preclinical data
Naoto Ueno, MD, PhD
12:20-12:40 Molecular Imaging (macrophages)
Carolien Schröder, MD, PhD
12:40-13:00 Panel Discussion
13:00-14:30 LUNCH with Case Presentations (Beth Overmoyer, Massimo Cristofanilli, Naoto Ueno)
14:30-16:50 Session 2: EPIDEMIOLOGY
Moderator: Sofia Merajver, MD
14:30-14:50 International Data-Tunisia
Hamouda Boussen, MD
14:50-15:10 International Data – Egypt
M. El-Shinawi, MD
 15:10-15:40 Panel discussion
15:40-16:40 Coffee BREAK and Poster viewing
16:40-18:20 Session 3: PATHOLOGY and IMMUNE MICROENVIRONMENT
 Moderator: Naoto Ueno, MD, PhD
16:50-17:10 The Pathology of IBC vs non-IBC
Savitri Krishnamurthy, MD
17:10-17:30 Understanding Tumor Microenvironment of IBC
Sofia Merajver, MD
o Stroma and Macrophages
17:30-17:50 Study of the immune infiltrate in IBC
Christophe Van Berckelaer, PhD
17:50-18:00 Checkpoint Inhibitors and PD-L1
Stephen Van Laere, MD, PhD
18:00-18:20 Panel Discussion
FRIDAY

Friday, September 21

08:30-9:30 Poster viewing
09.30-11.30 Session 1: MODELING and BIOINFOMATICS
Moderator: Gayathri Devi, MSc, PhD
09:30-09:50 Biology of IBC vs. BC from spontaneous animal models
Laura Peña, PhD
09:50- 10:10 Multiscale Modeling of the Unique Progression of Inflammatory Breast Cancer
Gayathri Devi, MSc, PhD
10:10- 10:30 Emboli Modeling
Kenneth van Golen, PhD
10:30-10:50 Collective Migration and IBC
Charlotte Rypens, PhD
10:50-11:10 Bioinformatics-NGS in advanced BC
Firas Wehbe, MD, PhD
11:10-11:30 Panel Discussion
11:30-12:00 Coffee  BREAK and Poster viewing
12.00-13.20 Session 2: RADIATION THERAPY and SURGERY
Moderator: Wendy Woodward, MD, PhD
12:00-12:20 Radiation Therapy and Radiosensitizers in IBC
Wendy Woodward, MD, PhD
12:20-12:40 CNS Targeting and Management in IBC
Wendy Woodward, MD, PhD
12:40-13:00 Breast Surgery/De Novo – Contralateral in IBC
Lisa Newman, PhD
13:00-13:20 Panel Discussion
13:20-14:40 LUNCH
14:40-16:00 Session 3: NOVEL TARGETS, CLINICAL TRIALS, INTERNATIONAL COLLABORATION
Moderator: Kenneth van Golen
14:40-15:00 Unique Signalling Pathways
Kenneth van Golen, PhD
15:00-15:30 Future Novel Clinical Trials
Peter Fasching, MD
o Neoadjuvant
15:30-16:00 International Collaborative Research and Plans for 2019-2020
IBC-IC Members
16:00-16:30 Coffee BREAK and Poster viewing
16:30-18:00 Poster discussion and AWARDS
18:00-19:00 Final Wrap-up
Massimo Cristofanilli, MD
Laura Peña, PhD
19:00-20:30 Cocktail
Contact Us

Send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt